Neurointerventional Devices Market Report 2026 Market Outlook Supported By A Forecast 7.1% CAGR

The neurointerventional devices market is set to experience significant expansion over the coming years, driven by advances in medical technology and growing healthcare needs. This sector is evolving rapidly as new innovations and increasing investments reshape treatment options for neurovascular conditions. Let's explore the market size projections, key players, important trends, and segmentation details that define this dynamic industry.

Expected Market Size and Growth Trajectory of the Neurointerventional Devices Market
The neurointerventional devices market is projected to reach a valuation of $3.91 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.1%. This growth is fueled by several factors such as an aging global population, increased funding for neurovascular research, the expansion of comprehensive stroke centers, heightened demand for quicker reperfusion treatments, and rising healthcare spending in emerging countries. Key trends anticipated during the forecast period include advancements in image-guided neurointervention, a growing preference for minimally invasive stroke therapies, wider adoption of flow diversion technologies, increased use of rapid clot retrieval devices, and the rising prevalence of neurointerventional procedures in developing markets.

Download a free sample of the Neurointerventional Devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25846&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Shaping the Neurointerventional Devices Market Landscape
The neurointerventional devices sector is dominated by a range of prominent companies, including Medtronic plc, Stryker Corporation, Johnson And Johnson, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co Ltd, MicroVention Inc, Phenox GmbH, Balt Group SAS, Balton Sp z o o, Zylox Tonbridge Medical Technology Co Ltd, Veiva Scientific Co Ltd, InspireMD Inc, Rapid Medical Ltd, Wallaby Medical, and Cerus Endovascular Ltd.

In September 2024, Boston Scientific, a US-based medical technology firm, acquired Silk Road Medical for about $1.18 billion. Through this acquisition, Boston Scientific aims to broaden its vascular surgery portfolio, strengthen its stroke prevention product line, and accelerate its mission to transform vascular disease treatments. Silk Road Medical specializes in devices like transcarotid artery revascularization systems, including the ENROUTE transcarotid neuroprotection and stent systems.

View the full Neurointerventional Devices market report:
https://www.thebusinessresearchcompany.com/report/neurointerventional-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Current Trends and Innovations Advancing the Neurointerventional Devices Market
Many key players in the neurointerventional devices industry are concentrating on developing novel solutions such as large-bore aspiration reperfusion catheters with sophisticated delivery mechanisms. These catheters are designed to provide strong distal vacuum aspiration directly at clot sites. Compared to traditional stent-retriever methods, they focus on direct aspiration (sometimes combined with additional devices) to clear occlusions with fewer device passes, reduced complexity at the clot site, and potentially faster procedures.

For example, in May 2024, Penumbra Inc., a US-based medical device company, introduced the RED 43, RED 72 with SENDit Technology, and RED 78-a family of neurovascular reperfusion catheters launched in Europe that expand the company's aspiration-based thrombectomy product offerings. These RED devices feature multi-layer catheter shafts combining PTFE liners with hybrid stainless steel/nitinol coils and precision polymer distal tips, which balance lumen size with enhanced trackability. They work by advancing the catheter close to the thrombus and applying suction via Penumbra's ENGINE aspiration source to extract the clot. Unique design elements include engineered transition zones and REDglide technology, which improve catheter deliverability through complex vessel pathways and offer a range of lumen sizes.

Breakdown of the Neurointerventional Devices Market by Product, Application, and Geography
This report segments the neurointerventional devices market as follows:

By Product:
- Embolic Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy Devices
- Embolic Protection Devices
- Flow Diverters Devices
- Intrasaccular Devices
- Other Products

By Indication:
- Brain Aneurysm
- Stroke
- Other Indications

By Technique:
- Neurothrombectomy Procedures
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption

By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research Institutes

Additional subcategories provide further detail, including:

Embolic Coils divided into Bare Platinum Coils, Coated or Modified Coils, Complex-Shaped Coils, and Detachable Coils;
Carotid Stents categorized into Open-Cell, Closed-Cell, Hybrid-Cell, and Drug-Eluting Stents;
Intracranial Stents subdivided into Self-Expanding, Balloon-Expandable, and Drug-Eluting Stents;
Neurovascular Thrombectomy Devices including Stent Retrievers, Aspiration Catheters, and Combined Thrombectomy Systems;
Embolic Protection Devices such as Distal Filters, Proximal Occlusion Devices, and Distal Occlusion Devices;
Flow Diverters Devices listed as Braided, Dual-Layer, and Coated Flow Diverters;
Intrasaccular Devices comprising Woven Mesh Implants, Expandable Mesh Baskets, and Flow Disrupting Implants;
Other Products encompassing Microcatheters, Guidewires, Balloon Catheters, and Distal Access Catheters.

This comprehensive segmentation offers a nuanced understanding of the neurointerventional devices market, highlighting the vast array of products and applications that are shaping its growth worldwide.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.